An update from NovaBay Pharma ( (NBY) ) is now available.
NovaBay Pharmaceuticals is gearing up for a pivotal Special Meeting on November 22, 2024, to discuss an Asset Sale Transaction and Dissolution, urging stockholders to review the Proxy Statement for crucial details. The company filed this document with the SEC and plans to distribute it to its stockholders for informed voting. This meeting marks a significant moment for investors as it could reshape the company’s future.
For an in-depth examination of NBY stock, go to TipRanks’ Stock Analysis page.
